This inventor holds 4 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 1993-1996.
Company Filing History:
Years Active: 1993-1996
Title: Kevin M Brady: Innovator in Vascular Disease Treatment
Introduction
Kevin M Brady is a notable inventor based in Concord, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of plasminogen activators. With a total of 4 patents to his name, Brady's work has the potential to impact the treatment of vascular diseases.
Latest Patents
Brady's latest patents include innovative variants of plasminogen activators and processes for their production. One of his patents describes a fibrinolytically active amino acid sequence variant of a plasminogen activator that has one or more glycosylation sites in regions that are not glycosylated in the native molecule. This advancement allows for the preparation of DNA sequences that encode the variants, as well as expression vectors incorporating these DNA sequences. The transformed host cells can produce these variants, which may be utilized in pharmaceutical preparations to treat vascular diseases or conditions in patients. Another patent focuses on variants of tissue plasminogen activator, emphasizing similar methods and applications in the treatment of vascular conditions.
Career Highlights
Kevin Brady is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Genentech has allowed him to further his research and development efforts in the field of vascular disease treatment.
Collaborations
Brady has collaborated with esteemed colleagues such as Stephen P Anderson and Bruce A Keyt. These collaborations have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Kevin M Brady is a prominent inventor whose work in plasminogen activators holds promise for improving treatments for vascular diseases. His contributions to biotechnology continue to pave the way for innovative medical solutions.